Publications

5891 Results

Longterm adherence, toxicity, and dose-intensity in a head and neck chemoprevention trial

Authors
JJ Lee;ES Kim;FR Khuri;RM Chamberlain;L Feng;B Williams;K Fu;J Cooper;SM Lippman;WK Hong
Journal / Conference
Proc of the American Society of Clinical Oncology 22:91 (#364)
Year
2003
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9446

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters associated with clinical characteristics and outcome

Authors
C Wilson;M Mosquera-Caro;S Martin;G Davidson;Y Xu;K Ar;J Potter;IM Chen;D Pauler-Ankerst;H Gundacker;M Slovak;F Appelbaum;K Kopecky;CL Willman
Journal / Conference
Blood 102(11):(#602)
Year
2003
Research Committee(s)
Leukemia

Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer

Authors
MS Tallman;R Gray;NJ Robert;CF LeMaistre;CK Osborne;WP Vaughan;WJ Gradishar;TM Pisansky;J Fetting;E Paietta;HM Lazarus
Journal / Conference
New England Journal of Medicine 349(1):17-26
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9061 (EST-2190) (INT-0121)

The prostate cancer prevention trial: did the adherence interventions for the end of study biopsy really work?

Authors
S Carlin;P Goodman;C Moinpour;S Hill
Journal / Conference
Controlled Clinical Trials 24(3S):P222
Year
2003
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial

Authors
EM Messing;J Manola;G Wilding;K Propert;J Fleischmann;ED Crawford;JE Pontes;R Hahn;D Trump
Journal / Conference
Journal of Clinical Oncology 21(7):1214-1222
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8792 (INT-0079) (EST-2886)

SELECT: the selenium and vitamin E cancer prevention trial

Authors
EA Klein;IM Thompson;SM Lippman;PJ Goodman;D Albanes;PR Taylor;CA Coltman
Journal / Conference
Urologic Oncology 21(1):59-65
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The selenium and vitamin E cancer preventiion trial

Authors
EA Klein;SM Lippman;IM Thompson;PJ Goodman;D Albanes;PR Taylor;CA Coltman
Journal / Conference
World Journal of Urology 21(1):21-27
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study

Authors
GA Omura;MF Brady;KY Look;HE Averette;JE Delmore;HJ Long;S Wadler;G Spiegel;SG Arbuck
Journal / Conference
Journal of Clinical Oncology 21(15):2843-2848
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9238 (INT-0134) (GOG-134) (NCCTG-92-61-51)

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin - a gynecologic Oncology Group Study

Authors
RC Young;MF Brady;RK Nieberg;HJ Long;AR Mayer;SS Lentz;J Hurteau;DS Alberts
Journal / Conference
Journal of Clinical Oncology 21(23):4350-4355
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9047 (GOG-95)

Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: melacine

Authors
VK Sondak;JA Sosman
Journal / Conference
Seminars in Cancer Biology 13(6):409-415
Year
2003
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035